| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 15 | 2019 | 503 | 4.290 |
Why?
|
| Adipose Tissue | 6 | 2019 | 511 | 2.260 |
Why?
|
| Adipocytes | 4 | 2018 | 182 | 1.520 |
Why?
|
| Virus Replication | 6 | 2019 | 635 | 1.500 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2019 | 449 | 1.300 |
Why?
|
| HIV Infections | 14 | 2019 | 2048 | 1.280 |
Why?
|
| Granzymes | 3 | 2014 | 48 | 1.260 |
Why?
|
| HIV-1 | 10 | 2019 | 483 | 1.250 |
Why?
|
| CD28 Antigens | 5 | 2012 | 81 | 1.130 |
Why?
|
| Flow Cytometry | 9 | 2019 | 802 | 1.100 |
Why?
|
| HIV | 2 | 2015 | 190 | 0.810 |
Why?
|
| Immunologic Memory | 2 | 2014 | 199 | 0.730 |
Why?
|
| T-Lymphocytes | 7 | 2019 | 1757 | 0.730 |
Why?
|
| Viral Load | 4 | 2018 | 408 | 0.660 |
Why?
|
| Interleukin-7 | 2 | 2012 | 50 | 0.650 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2015 | 234 | 0.630 |
Why?
|
| CD36 Antigens | 1 | 2019 | 42 | 0.630 |
Why?
|
| Cell-Derived Microparticles | 2 | 2010 | 29 | 0.620 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 75 | 0.620 |
Why?
|
| DNA, Viral | 5 | 2016 | 490 | 0.610 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2018 | 99 | 0.610 |
Why?
|
| Cyclin T | 1 | 2019 | 33 | 0.600 |
Why?
|
| Virus Latency | 1 | 2019 | 63 | 0.590 |
Why?
|
| Apoptosis | 7 | 2012 | 1900 | 0.580 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2018 | 38 | 0.560 |
Why?
|
| Anti-HIV Agents | 3 | 2018 | 347 | 0.530 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2016 | 356 | 0.520 |
Why?
|
| Cytokines | 7 | 2014 | 1365 | 0.520 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2015 | 210 | 0.500 |
Why?
|
| Obesity | 3 | 2019 | 2394 | 0.480 |
Why?
|
| Macaca mulatta | 4 | 2019 | 506 | 0.480 |
Why?
|
| Interferon-gamma | 4 | 2015 | 539 | 0.480 |
Why?
|
| Cell Membrane | 2 | 2008 | 473 | 0.470 |
Why?
|
| Macrophages | 3 | 2018 | 692 | 0.440 |
Why?
|
| Receptors, CCR5 | 1 | 2014 | 31 | 0.440 |
Why?
|
| Tuberculosis | 2 | 2012 | 556 | 0.420 |
Why?
|
| Monocytes | 2 | 2016 | 342 | 0.420 |
Why?
|
| Antibodies, Monoclonal | 3 | 2012 | 1035 | 0.410 |
Why?
|
| Lymphocyte Activation | 7 | 2015 | 686 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2006 | 666 | 0.390 |
Why?
|
| Liver | 2 | 2019 | 1799 | 0.390 |
Why?
|
| Herpesvirus 1, Human | 1 | 2012 | 34 | 0.380 |
Why?
|
| Mitogens | 1 | 2012 | 31 | 0.380 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 37 | 0.370 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2012 | 11 | 0.370 |
Why?
|
| Capsid | 1 | 2012 | 147 | 0.370 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2011 | 15 | 0.360 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2011 | 29 | 0.360 |
Why?
|
| Tuberculin Test | 1 | 2012 | 123 | 0.350 |
Why?
|
| DNA | 6 | 2023 | 1478 | 0.330 |
Why?
|
| Cells, Cultured | 7 | 2018 | 3044 | 0.330 |
Why?
|
| Cryptosporidiosis | 6 | 2008 | 44 | 0.320 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 86 | 0.320 |
Why?
|
| Humans | 58 | 2023 | 131930 | 0.320 |
Why?
|
| Leukocyte Common Antigens | 3 | 2017 | 91 | 0.310 |
Why?
|
| Coculture Techniques | 3 | 2018 | 238 | 0.310 |
Why?
|
| Nucleic Acids | 1 | 2008 | 25 | 0.290 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 5 | 2013 | 56 | 0.280 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2019 | 17 | 0.270 |
Why?
|
| RNA, Viral | 3 | 2019 | 565 | 0.270 |
Why?
|
| Scleroderma, Systemic | 2 | 2023 | 129 | 0.270 |
Why?
|
| Trophoblasts | 1 | 2008 | 118 | 0.270 |
Why?
|
| Killer Cells, Natural | 3 | 2018 | 351 | 0.260 |
Why?
|
| AIDS Vaccines | 1 | 2007 | 30 | 0.260 |
Why?
|
| Th1 Cells | 3 | 2014 | 159 | 0.260 |
Why?
|
| Leukopenia | 1 | 2006 | 47 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2013 | 499 | 0.250 |
Why?
|
| Fetus | 4 | 2006 | 595 | 0.250 |
Why?
|
| Pre-Eclampsia | 1 | 2008 | 230 | 0.250 |
Why?
|
| Animals | 25 | 2019 | 34908 | 0.250 |
Why?
|
| RNA, Messenger | 3 | 2011 | 2676 | 0.250 |
Why?
|
| Gene Products, vpr | 2 | 2017 | 18 | 0.240 |
Why?
|
| Plasma | 1 | 2006 | 103 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2438 | 0.230 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 263 | 0.230 |
Why?
|
| Hypoxia | 1 | 2006 | 259 | 0.220 |
Why?
|
| Antigens, CD | 4 | 2015 | 436 | 0.220 |
Why?
|
| Neoplasms | 2 | 2019 | 2953 | 0.220 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 12 | 0.220 |
Why?
|
| Signal Transduction | 7 | 2018 | 4717 | 0.220 |
Why?
|
| Cryptosporidium | 3 | 2008 | 34 | 0.210 |
Why?
|
| CD4 Antigens | 4 | 2017 | 56 | 0.200 |
Why?
|
| Forkhead Transcription Factors | 4 | 2010 | 387 | 0.200 |
Why?
|
| Cell Line | 7 | 2019 | 2724 | 0.200 |
Why?
|
| Interleukin-6 | 2 | 2018 | 435 | 0.200 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 61 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 826 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 579 | 0.180 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2017 | 235 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1408 | 0.170 |
Why?
|
| Anemia, Sickle Cell | 2 | 2018 | 330 | 0.170 |
Why?
|
| Intestinal Mucosa | 4 | 2010 | 796 | 0.160 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2014 | 63 | 0.160 |
Why?
|
| Integrins | 2 | 2018 | 94 | 0.160 |
Why?
|
| PPAR alpha | 2 | 2017 | 55 | 0.160 |
Why?
|
| Male | 26 | 2019 | 64846 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 1552 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2012 | 270 | 0.150 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1422 | 0.150 |
Why?
|
| Cryptosporidium parvum | 3 | 2010 | 28 | 0.150 |
Why?
|
| Prenatal Diagnosis | 5 | 2004 | 633 | 0.150 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2019 | 19 | 0.150 |
Why?
|
| Karyopherins | 2 | 2019 | 39 | 0.150 |
Why?
|
| Mice | 13 | 2019 | 18534 | 0.150 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 123 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2011 | 1080 | 0.150 |
Why?
|
| Immune Evasion | 1 | 2018 | 39 | 0.140 |
Why?
|
| Fetal Blood | 3 | 2004 | 174 | 0.140 |
Why?
|
| Tenofovir | 1 | 2018 | 23 | 0.140 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 36 | 0.140 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2018 | 4 | 0.140 |
Why?
|
| Sphingosine | 1 | 2018 | 17 | 0.140 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 18 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 2 | 2018 | 150 | 0.140 |
Why?
|
| Immunological Synapses | 1 | 2018 | 30 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2018 | 33 | 0.140 |
Why?
|
| Integrin beta Chains | 1 | 2017 | 10 | 0.140 |
Why?
|
| Liver X Receptors | 1 | 2017 | 18 | 0.140 |
Why?
|
| Prodrugs | 1 | 2018 | 63 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 120 | 0.140 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 1350 | 0.140 |
Why?
|
| Female | 30 | 2017 | 70607 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 430 | 0.130 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 71 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 133 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2019 | 880 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 326 | 0.130 |
Why?
|
| Adult | 15 | 2017 | 31506 | 0.130 |
Why?
|
| Postprandial Period | 1 | 2016 | 91 | 0.120 |
Why?
|
| Photopheresis | 1 | 2015 | 5 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 240 | 0.120 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 8 | 0.120 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2013 | 38 | 0.120 |
Why?
|
| Jurkat Cells | 3 | 2018 | 86 | 0.120 |
Why?
|
| Enzyme Assays | 1 | 2014 | 12 | 0.110 |
Why?
|
| Lectins, C-Type | 2 | 2013 | 72 | 0.110 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 10 | 0.110 |
Why?
|
| Perforin | 1 | 2014 | 26 | 0.110 |
Why?
|
| Pregnancy | 9 | 2008 | 7545 | 0.110 |
Why?
|
| Blood Donors | 1 | 2014 | 61 | 0.110 |
Why?
|
| Cell Differentiation | 3 | 2013 | 1963 | 0.110 |
Why?
|
| Thrombopoiesis | 1 | 2014 | 12 | 0.110 |
Why?
|
| Lymphocyte Subsets | 2 | 2012 | 41 | 0.110 |
Why?
|
| Integrin beta3 | 1 | 2014 | 29 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4757 | 0.110 |
Why?
|
| Integrin alpha4beta1 | 1 | 2013 | 31 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2014 | 98 | 0.100 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2013 | 9 | 0.100 |
Why?
|
| B-Lymphocytes | 3 | 2013 | 543 | 0.100 |
Why?
|
| Chemokines, CC | 1 | 2013 | 27 | 0.100 |
Why?
|
| Aquaporin 2 | 1 | 2013 | 7 | 0.100 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2013 | 106 | 0.100 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2013 | 8 | 0.100 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 13 | 0.100 |
Why?
|
| Substance P | 2 | 2003 | 37 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 365 | 0.100 |
Why?
|
| Fluorescence | 2 | 2010 | 103 | 0.100 |
Why?
|
| Water-Electrolyte Balance | 1 | 2013 | 83 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2011 | 2509 | 0.100 |
Why?
|
| Intestines | 2 | 2007 | 606 | 0.090 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 419 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2018 | 822 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2013 | 82 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2011 | 16 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2018 | 3866 | 0.090 |
Why?
|
| RNA Stability | 1 | 2012 | 82 | 0.090 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2013 | 175 | 0.090 |
Why?
|
| Vagina | 1 | 2013 | 206 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2011 | 212 | 0.080 |
Why?
|
| Middle Aged | 11 | 2017 | 28893 | 0.080 |
Why?
|
| Aneuploidy | 4 | 2004 | 143 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3415 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 613 | 0.080 |
Why?
|
| Adenosine | 1 | 2010 | 135 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2010 | 182 | 0.080 |
Why?
|
| HTLV-I Infections | 1 | 2009 | 7 | 0.080 |
Why?
|
| Chemokines, CXC | 2 | 2006 | 38 | 0.080 |
Why?
|
| Interleukin-5 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Strongyloides stercoralis | 1 | 2009 | 22 | 0.080 |
Why?
|
| Strongyloidiasis | 1 | 2009 | 43 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 541 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2006 | 85 | 0.080 |
Why?
|
| Antiparasitic Agents | 2 | 2006 | 31 | 0.070 |
Why?
|
| Membrane Lipids | 1 | 2008 | 31 | 0.070 |
Why?
|
| Immunity, Cellular | 2 | 2007 | 203 | 0.070 |
Why?
|
| HIV Core Protein p24 | 1 | 2008 | 12 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2013 | 239 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 101 | 0.070 |
Why?
|
| Cell Separation | 2 | 2006 | 226 | 0.070 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 13 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 65 | 0.070 |
Why?
|
| Androstadienes | 1 | 2008 | 52 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 53 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2010 | 903 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2006 | 236 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2005 | 138 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 589 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 265 | 0.070 |
Why?
|
| Vaccination | 1 | 2013 | 1017 | 0.070 |
Why?
|
| CD4-CD8 Ratio | 1 | 2007 | 13 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2007 | 19 | 0.070 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Young Adult | 3 | 2017 | 9929 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 108 | 0.070 |
Why?
|
| Microspheres | 1 | 2006 | 74 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 58 | 0.060 |
Why?
|
| HIV Antibodies | 1 | 2007 | 71 | 0.060 |
Why?
|
| Neutralization Tests | 1 | 2007 | 237 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 324 | 0.060 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 134 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2007 | 241 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2003 | 774 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2006 | 104 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2007 | 364 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2006 | 145 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2006 | 155 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2005 | 122 | 0.060 |
Why?
|
| Biomarkers | 1 | 2014 | 3373 | 0.060 |
Why?
|
| Interleukin-15 | 1 | 2005 | 96 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 3688 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2004 | 47 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 1050 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2450 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2018 | 679 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2004 | 195 | 0.050 |
Why?
|
| Digestion | 1 | 2023 | 44 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 392 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2023 | 47 | 0.050 |
Why?
|
| Pulmonary Emphysema | 1 | 2004 | 94 | 0.050 |
Why?
|
| Sex Determination Analysis | 1 | 2003 | 16 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2141 | 0.050 |
Why?
|
| JC Virus | 1 | 2003 | 29 | 0.050 |
Why?
|
| Blood Cells | 1 | 2003 | 56 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 365 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 4688 | 0.050 |
Why?
|
| Taurochenodeoxycholic Acid | 1 | 2002 | 4 | 0.050 |
Why?
|
| Rotavirus Infections | 2 | 2004 | 359 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2002 | 26 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2004 | 201 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2004 | 439 | 0.050 |
Why?
|
| Somatostatin | 1 | 2002 | 63 | 0.050 |
Why?
|
| Polyomavirus Infections | 1 | 2003 | 90 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2002 | 590 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 2003 | 140 | 0.050 |
Why?
|
| Neurocysticercosis | 1 | 2002 | 27 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2006 | 558 | 0.050 |
Why?
|
| Granuloma | 1 | 2002 | 66 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2002 | 109 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 166 | 0.050 |
Why?
|
| Blood | 1 | 2002 | 103 | 0.040 |
Why?
|
| Gestational Age | 2 | 2002 | 1226 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 221 | 0.040 |
Why?
|
| Time Factors | 2 | 2013 | 6435 | 0.040 |
Why?
|
| Diarrhea | 1 | 2003 | 329 | 0.040 |
Why?
|
| Aged | 7 | 2016 | 21394 | 0.040 |
Why?
|
| Rotavirus | 1 | 2004 | 505 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 287 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2003 | 292 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 673 | 0.040 |
Why?
|
| Hepatocytes | 2 | 2017 | 239 | 0.040 |
Why?
|
| RNA Transport | 1 | 2019 | 9 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2019 | 270 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 370 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2018 | 29 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 137 | 0.040 |
Why?
|
| Caco-2 Cells | 2 | 2010 | 94 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 628 | 0.030 |
Why?
|
| Gene Expression | 1 | 2002 | 1563 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 551 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 103 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 125 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 5394 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 266 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 126 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2018 | 184 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 592 | 0.030 |
Why?
|
| Adolescent | 3 | 2012 | 20524 | 0.030 |
Why?
|
| Chemokine CXCL10 | 2 | 2006 | 53 | 0.030 |
Why?
|
| Inflammation | 2 | 2018 | 1521 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1731 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1652 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 382 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 120 | 0.030 |
Why?
|
| Activin Receptors, Type II | 1 | 2014 | 34 | 0.030 |
Why?
|
| Cell-Free System | 2 | 2004 | 66 | 0.030 |
Why?
|
| Activins | 1 | 2014 | 73 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 54 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 2013 | 45 | 0.030 |
Why?
|
| Activin Receptors, Type I | 1 | 2014 | 35 | 0.030 |
Why?
|
| Chromosomes, Human, Y | 2 | 2004 | 52 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 58 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 58 | 0.030 |
Why?
|
| Carcinogens | 1 | 2014 | 128 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2014 | 120 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2013 | 89 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2014 | 141 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 304 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 174 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2013 | 85 | 0.020 |
Why?
|
| Polyuria | 1 | 2013 | 11 | 0.020 |
Why?
|
| Proteolysis | 1 | 2014 | 195 | 0.020 |
Why?
|
| Disease Progression | 2 | 2013 | 2222 | 0.020 |
Why?
|
| Acid-Base Imbalance | 1 | 2013 | 25 | 0.020 |
Why?
|
| Cadherins | 1 | 2014 | 180 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 212 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 208 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 516 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2012 | 45 | 0.020 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2013 | 77 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 689 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 159 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 165 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1294 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1604 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 376 | 0.020 |
Why?
|
| Xanthines | 1 | 2010 | 11 | 0.020 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 358 | 0.020 |
Why?
|
| Lung | 2 | 2010 | 1556 | 0.020 |
Why?
|
| Adenosine Deaminase | 1 | 2010 | 89 | 0.020 |
Why?
|
| Hemolysis | 1 | 2010 | 107 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1613 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2005 | 1226 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2013 | 448 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 271 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 79 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2010 | 95 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 531 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2010 | 219 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 24 | 0.020 |
Why?
|
| Antigens, Helminth | 1 | 2009 | 188 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 123 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2008 | 82 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 753 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2006 | 11 | 0.020 |
Why?
|
| Antibodies, Viral | 2 | 2004 | 1204 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2006 | 28 | 0.020 |
Why?
|
| Chemokines | 1 | 2006 | 130 | 0.020 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2005 | 5 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2005 | 16 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 241 | 0.010 |
Why?
|
| Ileum | 1 | 2005 | 130 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2004 | 23 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 47 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1045 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 12 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 127 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 138 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 2004 | 22 | 0.010 |
Why?
|
| Random Allocation | 1 | 2005 | 431 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1326 | 0.010 |
Why?
|
| Virion | 1 | 2004 | 151 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2003 | 4 | 0.010 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2003 | 18 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 5004 | 0.010 |
Why?
|
| Caspase 12 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Caspase 7 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2002 | 23 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1719 | 0.010 |
Why?
|
| Jejunum | 1 | 2003 | 131 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 1130 | 0.010 |
Why?
|
| Taenia | 1 | 2002 | 5 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 141 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 50 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2002 | 170 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2002 | 22 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 69 | 0.010 |
Why?
|
| Pregnancy Trimester, First | 1 | 2002 | 124 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 341 | 0.010 |
Why?
|
| Granulocytes | 1 | 2002 | 69 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 195 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2002 | 44 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 234 | 0.010 |
Why?
|
| Mothers | 1 | 2004 | 372 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 216 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 618 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 1450 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1285 | 0.010 |
Why?
|
| Placenta | 1 | 2004 | 541 | 0.010 |
Why?
|
| Mosaicism | 1 | 2002 | 250 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 358 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 550 | 0.010 |
Why?
|
| Down Syndrome | 1 | 2002 | 232 | 0.010 |
Why?
|
| Smoking | 1 | 2004 | 940 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2003 | 462 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 2897 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2002 | 385 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3771 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 1078 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 751 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 2703 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 17345 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2163 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2003 | 1098 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 1876 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 3358 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 6526 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 6245 | 0.000 |
Why?
|